Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) Target Price at $613.10

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been given an average recommendation of “Moderate Buy” by the twenty-one ratings firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $613.10.

A number of equities analysts recently weighed in on ISRG shares. UBS Group upped their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Barclays lifted their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. CICC Research initiated coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price target for the company. Finally, Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th.

Insider Activity at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,240 shares of company stock worth $3,529,040 in the last 90 days. 0.80% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds have recently modified their holdings of the business. Howard Capital Management Group LLC grew its stake in Intuitive Surgical by 4.5% in the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after purchasing an additional 92 shares during the last quarter. Foundations Investment Advisors LLC boosted its holdings in shares of Intuitive Surgical by 8.5% in the 3rd quarter. Foundations Investment Advisors LLC now owns 590 shares of the medical equipment provider’s stock valued at $290,000 after buying an additional 46 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of Intuitive Surgical by 4.2% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 7,618 shares of the medical equipment provider’s stock worth $3,742,000 after acquiring an additional 308 shares in the last quarter. Stanley Laman Group Ltd. purchased a new stake in Intuitive Surgical during the third quarter valued at approximately $271,000. Finally, Private Advisor Group LLC boosted its stake in Intuitive Surgical by 6.4% in the third quarter. Private Advisor Group LLC now owns 14,910 shares of the medical equipment provider’s stock valued at $7,325,000 after acquiring an additional 891 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 2.9 %

Shares of Intuitive Surgical stock opened at $573.74 on Friday. The company has a market capitalization of $204.35 billion, a price-to-earnings ratio of 89.51, a PEG ratio of 5.85 and a beta of 1.39. The stock’s 50-day simple moving average is $567.01 and its 200-day simple moving average is $527.27. Intuitive Surgical has a 52 week low of $364.17 and a 52 week high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.